Golvatinib T6517
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Golvatinib is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity. c-Met/VEGFR kinase inhibitor E7050
CAS nr:
928037-13-2
Purity:
98%
Molecular Weight:
633,69
SMILES:
C1(CC1)(C(=O)Nc1c(cc(cc1)Oc1cc(ncc1)NC(=O)N1CCC(CC1)N1CCN(CC1)C)F)C(=O)Nc1ccc(cc1)F
Formula:
C33H37F2N7O4
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors
Target:
VEGFR,VEGFR,c-Met/HGFR
